Market Overview

UPDATE: Morgan Stanley Downgrades Johnson Controls on Near-Term Volatility

Related JCI
Why Did Johnson Controls Suddenly Decided To Separate Its Automotive Business?
Benzinga's Volume Movers
UBS Sees Upside Potential in Horizon Pharma (HZNP), Johnson Controls (JCI) and Nike (NKE) (Small Cap Network)

In a report published Monday, Morgan Stanley analyst Ravi Shanker downgraded the rating on Johnson Controls (NYSE: JCI) from Overweight to Underweight, and lowered the price target from $45.00 to $40.00.

In the report, Morgan Stanley noted, “We moved JCI near the top of our rankings a year ago because we saw far more scenarios where JCI could win than lose. However, with execution back on track, a new CEO lobbying for change and the stock at $43, expectations into the analyst day may be too high.”

Johnson Controls closed on Friday at $42.53.

Latest Ratings for JCI

Jun 2015MacquarieMaintainsNeutral
Jun 2015Buckingham ResearchAssumesBuy
May 2015UBSUpgradesNeutralBuy

View More Analyst Ratings for JCI
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ravi ShankerAnalyst Color Downgrades Analyst Ratings


Related Articles (JCI)

Around the Web, We're Loving...

Get Benzinga's Newsletters